Search results
Author(s):
Tom Nelson
,
Pankaj Garg
,
Richard H Clayton
,
et al
Added:
3 years ago
Ventricular tachycardia (VT) and VF occur mainly in people with impaired cardiac function and/or ischaemic heart disease, and account for the majority of sudden cardiac deaths worldwide.1 Treatment with anti-arrhythmic drugs such as amiodarone may be at best neutral in terms of mortality and carries significant long-term risks.2,3 While ICDs significantly improve survival for patients with…
View more
Author(s):
Philippe Charron
,
Eloisa Arbustini
,
Gisèle Bonne
Added:
3 years ago
Most mutations of the LMNA gene affect the heart, causing a dilated cardiomyopathy, ususally with conduction defect and ventricular arrhythmia, with or without skeletal muscle involvement. Although a relatively rare disease, cardiologists should be aware of laminopathies (diseases caused by LMNA gene mutations) because of the particularly aggressive course compared with most other…
View more
Author(s):
Ethan R Ellis
,
Mark E Josephson
Added:
3 years ago
Cardiomyopathies are heterogeneous heart muscle disorders with a wide range of aetiologies and clinical manifestations. They are often defined by their causes (i.e. hypertension, prior myocardial infarction, valvular heart disease), although current major society definitions describe cardiomyopathy as the presence of abnormal myocardial structure and/or function in the absence of underlying…
View more
Author(s):
Laurent Roten
,
Matthew Daly
,
Patrizio Pascale
,
et al
Added:
3 years ago
With an ageing population and widespread use of implantable cardioverter-defibrillators, physicians are confronted with an increasing number of patients with symptomatic, drug-refractory ventricular tachycardia (VT). Catheter ablation is an important treatment option in the management of patients with structural heart disease and VT.1,2 In many patients, VT can be successfully ablated from the…
View more
Carina Blomström-Lundqvist
Research Area(s) / Expertise:
Author
Expertise
Electrophysiology & ArrhythmiaAtrial FibrillationCatheter Ablation of Cardiac ArrhythmiasStandards & GuidelinesInherited and Congenital Cardiac ConditionsHeterogeneous PopulationsVentricular ArrhythmiasCV Disease in Special PopulationsSupraventricular TachycardiaAtrial ArrhythmiasPrevention & Chronic Conditions
Author(s):
Angelo Auricchio
Added:
3 years ago
Despite the fact that more than 20 years have passed since the clinical introduction of cardiac resynchronisation therapy (CRT), one of the key questions – do we need an ICD for primary prevention of sudden cardiac death (SCD) in CRT patients? – is still unanswered.
Prospective Randomised Controlled Trials
Multiple prospective randomised controlled trials have been conducted to establish the…
View more
Author(s):
Shane E Loeffler
,
Natalia A Trayanova
Added:
1 year ago
Sanjay Prasad
Job title: Consultant in cardiology and cardiovascular magnetic resonance Professor of cardiomyopathy
Author
Author(s):
Ling Kuo
,
Jackson J Liang
,
Saman Nazarian
,
et al
Added:
3 years ago
Catheter ablation has been increasingly used as a treatment for refractory ventricular tachycardia (VT) in patients with non-ischaemic cardiomyopathy (NICM). However, ablation outcomes tend to be quite variable because of the heterogeneity of the aetiology for the NICM and associated VT substrate in these patients.1–3 Patients with NICM can be sub-classified based on specific genotypic and…
View more
Author(s):
Joshua R Silverstein
,
Demosthenes G Katritsis
,
Mark E Josephson
Added:
3 years ago
Sudden cardiac death (SCD) is one of the leading causes of death in developed countries. The yearly incidence of SCD is estimated to be 3,000,000 worldwide and between 300,000–450,000 in both the US and Western Europe.1,2 The survival rate for SCD is <1 % worldwide and close to 5 % in the developed world.3 In the past, cardiac arrest was thought to be most commonly due to ventricular…
View more